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ARTICLE
Quantal Release of ATP in Mouse Cortex
Yuriy Pankratov, Ulyana Lalo, Alexei Verkhratsky, and R. Alan North
Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK
Transient currents occur at rest in cortical neurones that refl  ect the quantal release of transmitters such as gluta-
mate and γ-aminobutyric acid (GABA). We found a bimodal amplitude distribution for spontaneously occurring 
inward currents recorded from mouse pyramidal neurones in situ, in acutely isolated brain slices superfused 
with picrotoxin. Larger events were blocked by glutamate receptor (AMPA, kainate) antagonists; smaller events 
were partially inhibited by P2X receptor antagonists suramin and PPADS. The decay of the larger events was selec-
tively prolonged by cyclothiazide. Stimulation of single intracortical axons elicited quantal glutamate-mediated 
currents and also quantal currents with amplitudes corresponding to the smaller spontaneous inward currents. 
It is likely that the lower amplitude spontaneous events refl  ect packaged ATP release. This occurs with a lower 
probability than that of glutamate, and evokes unitary currents about half the amplitude of those mediated through 
AMPA receptors. Furthermore, the packets of ATP appear to be released from vesicle in a subset of glutamate-
  containing terminals.
INTRODUCTION
An elementary event of synaptic transmission is a spon-
taneous release of packet or quantum of transmitter. 
At the neuromuscular junction this corresponds to 
the acetylcholine content of a single vesicle (Katz and 
Miledi, 1963), although in the central nervous system 
the situation is more complex (Redman, 1990; Auger 
and Marty, 2000). Such spontaneous neurotransmitter 
release is manifest electrically by miniature excitatory 
postsynaptic currents (mEPSCs) and miniature inhibi-
tory postsynaptic currents (mIPSCs). In the mamma-
lian central nervous system, the transmitters producing 
mEPSCs and mIPSCs are thought to be almost exclu-
sively glutamate and γ-aminobutyrate (GABA).
Ionotropic P2X receptors, at which extracellular ATP 
directly gates a cation-permeable channel, are widely 
expressed throughout the central nervous system 
(Collo et al., 1996; Verkhratsky et al., 1998; Norenberg 
and Illes, 2000; Verkhratsky and Steinhauser, 2000; 
Khakh, 2001; North, 2002; North and Verkhratsky, 
2006). Evoked synaptic transmission mediated by ATP 
acting at P2X receptors has been reported in several 
regions of CNS in situ, including medial habenula 
(Edwards et al., 1992; Edwards et al., 1997), hippocam-
pus (Pankratov et al., 1998; Mori et al., 2001), locus coe-
ruleus (Nieber et al., 1997), dorsal horn (Bardoni et al., 
1997; Jo and Schlichter, 1999), and cerebral cortex 
(Pankratov et al., 2002, 2003). However, the amplitude 
of the evoked synaptic currents remaining after block 
of glutamate receptors (and presumed to be puriner-
gic) is typically very small; some 5–15% of that of the 
initial unblocked current. The identifi  cation of such 
evoked synaptic currents has been hampered by their 
small amplitude and lack of highly selective P2X recep-
tor blockers.
Mechanisms of ATP release have proved controver-
sial, with proposals including mechanical deformation, 
gap junction hemichannels (Pearson et al., 2005), or 
the chloride channels of the cystic fi  brosis conductance 
regulator (for review see Sperlagh and Vizi, 2001). How-
ever, any central neurotransmitter role for ATP should 
be associated with the quantal release of ATP-storing 
vesicles, as was originally reported for the release of ATP 
from sympathetic nerves (Burnstock and Holman, 
1961). In neurones cultured from the lateral hypothala-
mus of the embryonic chick or neonatal mouse, sponta-
neous mEPSCs have also been observed in the presence 
of blockers of glutamate and GABA receptors (Jo and 
Role, 2002). Similarly ATP-mediated mEPSCs were 
occasionally detected in neurones from medial habenula 
(Edwards et al., 1997). Nevertheless, there has been no 
biophysical analysis of such events, no systematic reports 
of their occurrence in intact neuronal tissue and, more 
crucially, no effort to determine whether they corre-
spond to the unitary events underlying evoked purinergic 
transmission. The purpose of the present experiments 
was to test the hypothesis that ATP was released from 
vesicles in the cerebral cortex, and to measure the quan-
tal parameters of ATP-mediated component of evoked 
and spontaneous EPSCs.
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MATERIALS AND METHODS
Electrophysiology
CBL57 mice (15–45-d-old) were killed according to UK legisla-
tion. Brains were removed rapidly and placed into ice-cold saline 
(in mM) NaCl 138, KCl 3, CaCl2 0.5, MgCl2 2.5, NaH2PO4 
1, NaHCO3 25, glucose 15, pH 7.4 gassed with 95% O2–5% CO2. 
Transverse slices ( 300 μm) were kept for 1–4 h before recording 
at 22–24°C, in the above solution but with (in mM) CaCl2 2.5, 
MgCl2 1. Somatosensory cortex layer 2/3 neurones with pyrami-
dal shaped somata were selected using an infrared differential 
interference contrast optics, and recordings were made with patch 
pipettes (4 MΩ) fi  lled with (in mM) 50 KCl, 55 K-gluconate, 
10 NaCl, 10 HEPES, 2 MgATP, 0.1 EGTA, pH 7.35. In some experi-
ments, the intracellular solution was used to set the chloride 
reversal potential at −60 mV; it contained (in mM) 3 CsCl, 102 
Cs-gluconate, 10 NaCl, 10 HEPES, 2 MgATP, 0.1 EGTA, pH 7.35. 
The membrane potential was set at −80 mV unless stated other-
wise. Junction potentials were nulled with an open electrode in 
the recording chamber before each experiment. The series and 
the input resistances were 4–12 MΩ and 500–1,300 MΩ, respec-
tively; in cells accepted for analysis these varied by <20%.
EPSCs were evoked by stimulating axons originating from layer 
V neurones with a bipolar glass electrode (2–3-μm tip diameter) 
containing extracellular solution. The electrode was placed in 
layer V close to the layer IV border, stimulus duration was 100 μs, 
and the frequency was 0.3 Hz. The intensity was set either at a 
minimal level (10–20% higher in intensity than threshold at 
which EPSC appeared; typically 0.7–1.2 μA) or at a stronger level 
(evoked EPSCs with amplitude two to four times greater than 
those evoked by minimal stimulation, but also failures in at least 
10–20% of trials, typically 1.5–3 μA). Minimal level stimulation 
was set to meet the criteria of single-axon stimulation (Yoshimura 
et al., 2000) including all-or-none synaptic response, little varia-
tion in EPSC latencies, and absence of change in the mean size or 
shape of the EPSC with 20–50% increase in stimulus intensity. 
Hence minimal stimulation most likely activates a single fiber 
(Yoshimura et al., 2000; Rubio and Soto, 2001) whereas stronger 
stimulation would presumably activate several axons.
Spontaneous miniature excitatory synaptic currents (mEPSCs) 
were recorded in tetrodotoxin (1 μM) and picrotoxin (100 μM), 
except where stated. Currents were monitored using an EPC-9 
amplifi  er (HEKA), fi  ltered at 3.9 kHz, and digitized at 10 kHz. 
Experiments were controlled by PULSE/PULSEFIT software 
(HEKA) and data were analyzed by self-designed software.
Data Analysis
Quantal analysis of evoked synaptic currents was as previously 
described (Pankratov and Krishtal, 2003). Spontaneous inward 
currents of amplitude higher than two SD of baseline noise were 
selected, each analyzed in a 140-ms window (40 ms before and 
100 ms after peak). The mEPSC peak amplitude was determined 
using a computer routine based on the fi  tting of each current 
trace by the model curve with single exponential rise and decay 
phases. The minimal square root procedure was used to deter-
mine the amplitude of the model curve, while the time constants 
and offset were optimized by the gradient method to minimize 
the mean square error. The mean square error of the fi  t was 
<25% amplitude. A set of 800–1,500 mEPSCs or EPSCs was re-
corded and used for statistical analysis in each cell tested. Ampli-
tude distributions were analyzed with probability density functions 
and likelihood maximization techniques (Stricker et al., 1996a,b). 
The distributions of amplitude and decay time of spontaneous 
mEPSCs were fi  tted with bimodal function consisting with vari-
able peak location, width, and amplitude, and weights were calcu-
lated as the integrals of the corresponding Gaussian functions. 
Amplitude distributions of evoked EPSCs were fi  tted with multi-
quantal binomial or single-quantal models comprising two Gauss-
ian functions, with one peak location fi  xed at zero and the second 
variable peak.
RESULTS
Two Populations of mEPSCs
Amplitudes of mEPSCs showed a clear bimodal distribu-
tion with peaks at 7.1 ± 2.9 and 13.4 ± 4.8 pA (Fig. 1); 
in all 61 neurones this was best fi  t by two Gaussians 
(maximum likelihood method, P < 0.05). The overall 
mean amplitude (in 1 μM tetrodoxin and 100 μM pic-
rotoxin) was 11 ± 4 pA (n = 61), and the frequency 
Figure 1.  Two populations 
of mEPSC amplitudes. (A) 
Control mEPSCs in TTX 
(1  μM) and picrotoxin 
(100 μM), after addition (red) 
and washout (blue) of CNQX 
(50 μM), SYM2081 (3 μM), 
and d-APV (30 μM). (B) Am-
plitude histogram of mEPSCs 
from the cell shown in A. 
Note the disappearance of 
the larger peak after the inhi-
bition of glutamate receptors 
(red) and washout (blue).  Pankratov et al. 259
was 1.6 ± 0.7 Hz (n = 61; Fig. 1 A). The high-amplitude 
mEPSCs were selectively and reversibly blocked 
by glutamate receptor antagonists (AMPA/kainate 
receptor blockade: 50 μM 6-cyano-7-nitroquinoxaline-
2,3-dione [CNQX]; NMDA receptor blockade: 30 μM 
d-2-amino-5-phosphonovalerate [d-APV]; kainate re-
ceptor desensitization: 10 μM [2S,4R]-4-methylglutamic 
acid [SYM2081]; Fig. 1 B; we used a mixture of several 
ionotropic glutamate receptors antagonists and kain-
ate receptor desensitizing agent SYM2081 to ascertain 
complete inhibition of glutamate transmission). In this 
antagonist cocktail, mEPSCs of lower amplitude were 
observed in 41 of the 45 cells at 0.49 ± 0.28 Hz; their 
mean amplitude (7.6 ± 2.8 pA) was the same as that 
of the lower peak of the control bimodal distribution; 
their amplitude was unchanged even in a higher CNQX 
concentration (100 μM; n = 8). Selective inhibition of 
the higher amplitude mEPSCs was also observed with 
(a) AMPA/kainate receptor blocker 2,3-dihydroxy-6-nitro-
7-sulfamoyl-benzo(f)quinoxaline (NBQX, 100 μM) and 
d-APV (30 μM), n = 8; (b) CNQX (50 μM) and the 
nonspecifi  c glutamate receptor blocker kynurenic acid 
(2 mM), n = 5; and (c) the noncompetitive AMPA re-
ceptor (±)-4-(4-aminophenyl)-1,2-dihydro-1-methyl-2-
 propylcarbamoyl-6,7-methylenedioxyphthalazine (SYM 
2206, 50 μM) with SYM2081 (10 μM) and d-APV (30 μM), 
n = 7. These results strongly suggest that the residual 
low amplitude population of mEPSCs does not involve 
ionotropic glutamate receptors.
The low-amplitude mEPSCs were partially inhibited 
by PPADS (3 μM, Fig. 2 A) and suramin (10 μM, Fig. 
2 B), which both block most of P2X receptor subtypes 
(North and Surprenant, 2000). PPADS (3 μM) reduced 
the amplitude (by 24 ± 16%, n = 14) and frequency 
(by 43 ± 27%, n  = 8) of low-amplitude mEPSCs. 
When suramin was washed out and replaced by gluta-
mate receptor blockers (CNQX, SYM2081, and D-APV), 
the low-amplitude mEPSCs reappeared and the higher 
amplitude events were blocked (Fig. 2, B and C). 
When added in the presence of NBQX and d-APV, 
suramin (10 μM) also reduced the amplitude (by 55 ± 
8%, n = 7) and frequency (47 ± 24%, n = 7) of the 
low-amplitude residual mEPSCs (unpublished data). 
This effect was mimicked by the suramin analogue 
8,8’-(carbonylbis(imino-4,1-phenylenecarbonylimino-4,
1-phenylenecarbonylimino)) bis(1,3,5-naphthalen-
etrisulfonic acid) (NF279, 1 μM; see Rettinger et al., 
2000), which also substantially blocked the residual 
mEPSCs when added in the presence of NBQX and 
d-APV; the amplitude of mEPSCs was reduced by 
31 ± 9% and their frequency by 44 ± 20% (n = 5). 
8-Cyclopentyl-1,3-dipropylxanthine (DCPCX, 1 μM; an 
adenosine A1 receptor antagonist) and hexamethonium 
(100 μM; a nicotinic receptor blocker) had no effect 
on the mEPSCs.
Cyclothiazide reduces desensitization of AMPA recep-
tors (Partin et al., 1993). Cyclothiazide (50 μM) pro-
longed the decay of a subset of mEPSCs (Fig. 3). Thus, 
in cyclothiazide the distribution of τdecay changed from 
unimodal to bimodal (Fig. 3 C; τdecay 8.9 ± 1.6 and 16.8 ± 
2.5 ms, n = 5). The time constants of rise and decay 
Figure 2.  Selective block of high and low amplitude mEPSCs. 
(A) mEPSCs in control conditions, in CNQX (50 μM), SYM2081 
(10 μM), and d-APV (30 μM, 5 min; red), and after the further 
addition of PPADS (3 μM, 5 min; blue). Right panel shows distri-
butions of mEPSC amplitudes. Glutamate receptor blockade 
removed the high amplitude mEPSCs (red), and subsequent ad-
dition of PPADS reduced the amplitude of the remaining mEPSCs 
(blue). (B) mEPSCs in control conditions, in suramin (10 μM, 
5 min; blue), and after further addition of CNQX (50 μM), 
SYM2081 (10 μM), and d-APV (30 μM, 5 min; red). Right panel 
shows distributions of EPSC amplitudes. Note that suramin 
blocked the lower amplitude mEPSCs (blue), and subsequent 
addition of glutamate receptor blockers strongly reduced the 
occurrence of the larger mEPSCs (red). (C) Summary of the dif-
ferential sensitivity of low- and high-amplitude mEPSCs to suramin 
and ionotropic glutamate receptor antagonists. All recordings 
were made in TTX (1 μM) and picrotoxin (100 μM).260 Quantal ATP Release
of mEPSCs were not affected by CNQX (50 μM; con-
trol: τrise 1.1 ± 0.6 ms, τdecay 9.5 ± 1.9 ms, n = 65 cells; 
CNQX: τrise 1.2 ± 0.5 ms and τdecay 9.8 ± 2.1 ms, n = 61 
cells), but cyclothiazide did not change the decay of 
mEPSCs in the presence of CNQX (50 μM; Fig. 3 A). In 
cyclothiazide, PPADS (3 μM) substantially blocked the 
rapidly decaying mEPSCs, without much affecting the 
slower mEPSCs (Fig. 3). We hypothesize from these 
results that the population of smaller amplitude, cyclo-
thiazide-insensitive mEPSCs are mediated by ATP acting 
on P2X receptors.
Both populations (low and high amplitude) of mEPSCs 
were enhanced by α-latrotoxin, which is a potent stimu-
lator of vesicular exocytosis (Ushkaryov et al., 2004); 
latrotoxin (300 nM, 5–10 min) increased frequency of 
control mEPSCs by 84 ± 9% (n = 6) and low-amplitude 
nonglutamatergic mEPSCs by 127 ± 12% (n  = 6; 
unpublished data). Bafilomycin blocks vesicular re-
filling (Zhou et al., 2000); bafilomycin (1 μM, 2 h) 
reduced the frequency of mEPSC in control conditions 
by 95% (n = 4) and completely eliminated the low-
amplitude mEPSC in four cells tested.
ATP mEPSCs Are Independent of Glutamate 
and GABA Release
The asynchrony between the two populations of mEP-
SCs indicates that the release of ATP and glutamate is 
unrelated. However, there is evidence from cultured 
hypothalamic neurones that ATP might be coreleased 
with GABA (Jo and Role, 2002). To test for the core-
lease of ATP with GABA, we recorded spontaneous syn-
aptic currents in the presence of CNQX (50 μM) and 
d-APV (30 μM) but without picrotoxin. We used a 
cesium gluconate intracellular solution to separate the 
cationic currents through P2X receptors (reversal po-
tential  0 mV) and chloride currents through GABA 
receptors (reversal potential about −60 mV; the extra-
cellular solution contained TTX [1 μM] as well). Spon-
taneous events at −80 mV (Fig. 4 A) comprised of two 
types of inward current: one had smaller amplitude (6.9 ± 
2.1 pA) and faster decay (τdecay 9.7 ± 1.9 ms; 44 ± 10% 
of events), and the other larger amplitude (13.8 ± 3.7 
pA) and slower decay (τdecay 19.2 ± 5.5 ms; n = 6; 56 ± 
11% of events; n = 6 throughout).
At −40 mV, both inward (cationic) and outward (chlo-
ride) currents were observed (Fig. 4 A, bottom traces). 
Inward currents had τdecay of 9.9 ± 2.3 ms; they were 
resistant to bicuculline and inhibited by PPADS 
(3 μM: by 26 ± 12%, n = 4). They occurred at 41 ± 13% 
of the frequency of the events recorded at −80 mV 
(n = 6). Outward currents had τdecay of 21.1 ± 8.5 ms; 
they were abolished by bicuculline (30 μM,  n  = 6). 
They occurred at 50 ± 15% (n = 6) of the control fre-
quency. Therefore, these two distinct populations of 
spontaneous events are likely to be mediated by P2X 
receptors (inward, faster kinetics) and GABA receptors 
(outward, slower kinetics).
We infer that ATP is not released synchronously with 
GABA, because the superimposition of inward and out-
ward currents at −40 mV would result in currents of 
Figure 3.  Cyclothiazide selec-
tively prolongs larger mEPSCs. 
(A) A large mEPSC that is 
markedly prolonged by cyclo-
thiazide (50 μM, red) and a 
smaller mEPSC that is un-
affected by cyclothiazide. In 
PPADS (3 μM), cyclothiazide 
(50 μM) increased the dura-
tion of all mEPSCs, but in 
CNQX (50 μM), cyclothiazide 
had no effect on mEPSCs. 
(B) Distribution of decay time 
constants (τdecay) of mEPSCs. 
Black, control; red, cyclothi-
azide (50 μM); Blue, cyclothi-
azide and PPADS (3 μM). 
Note the appearance of slowly 
decaying mEPSCs in cyclo-
thiazide and the selective 
inhibition of faster decay-
ing mEPSCs by PPADS. (C) 
mEPSC  amplitude vs. decay 
time constant for control (top, 
1,700 events) and cyclothi-
azide (bottom, 900 events) 
for fi  ve cells. All recordings 
were in TTX (1 μM) and 
picrotoxin (100 μM).  Pankratov et al. 261
very small net amplitude and therefore lead to a de-
crease in the amplitude and frequency of apparent 
spontaneous currents. In fact, the sum of the frequen-
cies of fast inward (ATP-mediated) and slow outward 
(GABA-mediated) mEPSCs recorded at −40 mV was 
not different from that of all mEPSCs at −80 mV (Fig. 
4 B), which is consistent with the hypothesis of non-
coordinated release.
Quantal Analysis of Evoked EPSCs
Experiments using receptor antagonists suggested that 
a small component of the evoked EPSC (eEPSC) in rat 
cortical neurones results from ATP acting at P2X recep-
tors (Pankratov et al., 2002, 2003). This implies that uni-
tary components of the eEPSC corresponding to the 
ATP-mediated mEPSC should be detectable at this syn-
apse. Vertical axons originating from layer V neurones 
were stimulated with either minimal or stronger stimu-
lation (see Materials and methods). Minimal stimula-
tion most likely activated a single fi  ber providing input 
to the pyramidal neurone (Gil et al., 1999; Yoshimura 
et al., 2000), whereas stronger stimulation presumably 
activated several axons. We recorded excitatory synaptic 
currents, evoked and spontaneous, fi  rst in picrotoxin 
(100 μM) and d-AP5 (30 μM), which were our control 
condition and then again after further addition of 
CNQX (50 μM) and SYM2081 (10 μM; Fig. 5).
The results were of two kinds. In 19 out of 35 cells, the 
EPSC evoked by minimal stimulation was completely 
blocked by CNQX and SYM2081 (Fig. 5 A, top). The am-
plitude distribution of the evoked EPSC had a single 
peak located at  4–12 pA (Fig. 5 B, top); it was better fi  t 
by a single-quantal model than by a unimodal nonquan-
tal model (confi  dence level α < 0.01, n = 19) or a multi-
quantal binomial model (α < 0.05 for 14 of 19 cells). 
The average quantal size was 9.3 ± 5.2 pA; the difference 
between quantal size of the unitary evoked EPSC and 
the mean amplitude of spontaneous glutamatergic 
mEPSC was not statistically signifi  cant (P > 0.05, ANOVA 
test). With stronger stimulation in these cells, eEPSCs 
were observed in the presence of glutamate receptor an-
tagonists in all 19 cells tested  (Fig. 5 B, bottom); these 
residual eEPSCs were decreased in amplitude by 39 ± 
17% in PPADS (10 μM,  n  = 4), similar to previous 
results (Pankratov et al., 2002, 2003). The eEPSC ampli-
tude distribution exhibited multiple peaks (Fig. 5 B, 
bottom) and was well fi  t by a multiquantal binomial 
model (confi  dence level α < 0.05) for all 19 cells. The 
maximal number of quanta was 2.4 ± 1.3, the mean 
quantal content (product of number of quanta and re-
lease probability) was 1.4 ± 0.8 (n = 19), and the quan-
tal size was 9.2 ± 5.5 pA. This amplitude distribution 
became single quantal in glutamate receptor antagonists 
(CNQX, SYM2081; in 14 of 19 cells; Fig. 5 B, bottom). 
The average quantal size of the residual component was 
6.8 ± 2.9 pA; the maximal number of quanta was 1.6 ± 0.9, 
and the mean quantal content was 0.36 ± 0.15 (n = 19). 
These results indicate that the minimal stimulation 
results in synaptic transmission at a single synapse that 
does not have any purinergic component, but that an in-
crease in the stimulus strength recruits further fi  bers 
that result in synaptic transmission at additional syn-
apses, some of which do have a purinergic component.
In the second group (16 of 35 cells), the EPSC evoked 
with minimal stimulation was not completely blocked 
Figure 4.  ATP release is asynchronous with GABA release. (A) 
Representative spontaneous currents recorded in TTX (1 μM), 
CNQX (50 μM), and d-APV (30 μM), in neurones with cesium-
gluconate intracellular solution (ECl = −60 mV). At −80 mV, all 
currents are inward, but some decay more slowly than others. At 
−40 mV, GABA-mediated currents are outward (red arrows) and 
ATP-mediated currents are inward (blue arrows). Bicuculline 
(30 μM) completely inhibited outward currents. (B) Distribution 
of inactivation time constants (τdecay) of currents recorded at −80 
mV (binominal distribution corresponding to two populations of 
currents) and at −40 mV. At −40 mV, the outward currents 
(GABA mediated, red) decay much more slowly than the inward 
currents (ATP mediated, blue).262 Quantal ATP Release
by the glutamate receptor antagonists (Fig. 6 A); the re-
sidual current was partially inhibited by purinergic an-
tagonist PPADS. The amplitude distribution of eEPSCs 
at minimal stimulation was very different from that seen 
in the fi  rst group of cells, because it exhibited several 
(typically three) peaks; this changed to a single peak 
after blockade of glutamate receptors (Fig. 6 B). The ini-
tial amplitude distribution was best fi  t by a compound 
model with two separate underlying components (Fig. 
6 B). The fi  rst was single quantal in all 16 cells and had 
lower release probability and smaller quantal size, simi-
lar to the quantal size of the current remaining in 
CNQX and SYM2081 (component “1,” Fig. 6 C). The 
second component had a larger quantal size and was 
single quantal in 11 cells (α < 0.01) and multiquantal 
in fi  ve cells (α < 0.05 for three cells and < 0.1 for two 
cells; component “2,” Fig. 6 C). The mean quantal con-
tent of the ATP-mediated and glutamate-mediated com-
ponents were 0.23 ± 0.9 and 0.82 ± 0.44 (n = 16), 
respectively; the quantal size of these components were 
6.2 ± 3.3 pA and 9.1 ± 5.7 pA, respectively (n = 16). 
These values agree with the quantal size of purinergic 
and glutamatergic EPSCs in the fi  rst group of cells.
The value of quantal size in the evoked EPSC gives an 
estimate for the unitary properties of the synaptic cur-
rent, whether this corresponds to a single postsynaptic 
site or a single synaptic vesicle (Auger and Marty, 2000); 
these estimates can therefore be compared with the 
properties of the spontaneous mEPSCs. The quantal size 
of the evoked purinergic EPSC was 74 ± 16% (n = 35) 
of the control evoked EPSC (i.e., before adding glu-
tamate receptor blockers). The corresponding value for 
the mEPSCs in the same cells was 73 ± 11% (n = 35). 
After glutamate receptor blockade, there was also no 
difference between the mean amplitude of the unitary 
evoked EPSC and the spontaneous mEPSC (P < 0.01, 
ANOVA test). These results suggest that both evoked 
EPSCs and spontaneous ATP-mediated mEPSCs origi-
nate from the same synapses.
This conclusion is supported by the effect of chang-
ing the intensity of stimulation on ATP-mediated spon-
taneous currents. We observed that the frequency of 
ATP-mediated mEPSCs recorded between stimulations 
was higher when the stronger stimulation was applied 
(Fig. 5). The increase in the purinergic mEPSC fre-
quency was 91 ± 57% as compared with that recorded 
in between episodes of minimal stimulation (n = 8). 
This indicates the appearance of new spontaneous 
events after activation of additional axons/terminals by 
the stronger stimulus. One feasible explanation for this 
could be an enhancement of the release due to a resid-
ual increase in the background calcium level in the pre-
synaptic terminals after repetitive stimulation. Another 
explanation might be the recruitment of P2X receptors 
to the synaptic membrane following the glutamate re-
ceptor activation. Whatever the mechanism, the appear-
ance of new spontaneous events suggests that they occur 
at the same terminals as the evoked currents.
Unitary purinergic currents were observed in  45% 
cases of single-fi  ber (minimal) stimulation and in 100% 
cases of multifi  ber (stronger) stimulation. At the same 
time, the purinergic EPSC was always accompanied by a 
Figure 5.  Evoked and spontaneous EPSCs. (A) Minimal stimulation evoked EPSCs, which often fail; these are blocked by CNQX 
(50 μM) and SYM2081 (10 μM). Stronger stimulation evoked EPSCs, which sometimes fail, but which are incompletely blocked by the gluta-
mate antagonists. (B) Amplitude distributions of the EPSCs evoked by minimal (top panel) and stronger stimulation (bottom panel) 
before and after adding glutamate receptor blockers (50 μM CNQX and 10 μM SYM2081). (C) Time course of experiment such as 
illustrated in A. Top graph shows the amplitudes of evoked EPSCs and bottom graph shows amplitudes of spontaneous mEPSCs, 
recorded in between the stimulations. All in picrotoxin (100 μM) and d-APV (30 μM).  Pankratov et al. 263
glutamate-mediated unitary current; in all 35 cells tested 
there was no case of a purely purinergic current by single-
fiber stimulation. On this ground, the existence of 
specifi  c purinergic axons seems unlikely. Our result is 
best ascribed to the vesicular release of ATP at some of 
the same synapses as glutamate.
We were unable to distinguish between the ATP-
mediated eEPSCs (i.e., in 50 μM CNQX and 10 μM 
SYM2081) and the glutamate-mediated eEPSCs (i.e., 
in control conditions) by a range of further proper-
ties. First, we did not observe any signifi  cant difference 
in the latency of purinergic and glutamatergic evoked 
synaptic currents. Second, the paired-pulse ratio (see 
Materials and methods) was 1.01 ± 0.25 (n = 24) for 
the former, and 1.04 ± 0.21 (n = 16) for the latter (un-
published data); in individual cells the paired-pulse 
ratio was well correlated for the glutamatergic and 
purinergic currents (R > 0.99, P < 0.02). Baclofen (3 μM) 
decreased the amplitude of the first and second 
EPSCs, increased the number of failures (zero synaptic 
responses) and increased the paired-pulse ratio; the 
effects were the same for both control currents and 
currents after glutamate receptor blockade. It is well at-
tested that metabotropic glutamate receptors (mGluRs) 
modulate synaptic strength in glutamatergic synapses 
(Simkus and Stricker, 2002; Schoepp 2001). In par-
ticular, activation of mGluRs group I (which activated 
InsP3-dependent Ca2+ release form intracellular stores) 
enhances (Simkus and Stricker, 2002), whereas stimula-
tion of mGluRs group III suppresses (Schoepp, 2001) 
synaptic transmission. We tested the effects of mGluR 
group III receptor agonist (1S,3R,4S)-1-aminocyclopen-
tane-1,2,4-tricarboxylic acid (ACPT-1; 10 μM; n = 5), 
which decreased the average amplitudes, increased 
the number of failures and decreased the paired-pulse 
ratio for both ATP-mediated and glutamate-mediated 
events. Finally, α-latrotoxin (330 nM; n = 4) increased 
the average amplitudes, decreased the failure rate and 
increased the paired-pulse ratio (unpublished data). All 
in all, experiments described above did not reveal any 
signifi  cant difference in the behavior of glutamatergic 
and purinergic EPSCs.
DISCUSSION
The main fi  nding of the present work is that two popula-
tions of mEPSC are found in mouse layer 2/3 cortical 
pyramidal cells. They can be distinguished by their 
amplitudes and pharmacological properties. The small 
mEPSCs have about one-half the amplitude of the pre-
dominant EPSCs, they persist in very high concentrations 
of AMPA receptor blockers and agents promoting kain-
ate receptor desensitization, and they are unaffected by 
cyclothiazide. These small mEPSCs correspond in their 
properties to a component of the evoked EPSC. They are 
partially blocked by antagonists of P2X receptors, but 
fi  rm conclusions about the identity of the underlying 
P2X receptor are not possible yet. The most abundant 
P2X receptor subunits in the cortex are P2X4 and P2X6, 
but others are also present (Collo et al., 1996; Rubio and 
Soto, 2001). The pharmacological properties of mouse 
P2X4 receptors do not correspond in detail to those of 
the mEPSCs. When expressed in HEK 293 cells, homo-
meric P2X4 receptors are insensitive to suramin (100 μM) 
but blocked by PPADS (IC50  10 μM; Jones et al., 2000). 
The mEPSCs in our experiments were partially blocked 
by suramin and PPADS, but these are far from reliable 
antagonists with which to identify the subunit specifi  city 
of P2X receptors. Not only are their effects species and 
subunit dependent, but they also block a range of other 
ion channels (North and Surprenant, 2000).
In our experiments we used rather moderate concen-
tration of PPADS to ensure washout. In our previous ex-
periments (e.g., Pankratov et al., 1998, 2003) we observed 
that effects of 10–30 μM of PPDAS were only partially re-
versible. We considered demonstration of reversible effect 
of antagonist being more preferable for pharmacological 
characterization; the interpretation of irreversible block 
Figure 6.  ATP-mediated current evoked at minimal stimulation. 
(A) EPSCs before and after CNQX (50 μM) and SYM2081 
(10 μM). (B) Time course of block by CNQX and SYM2081. (C) Am-
plitude distribution of EPSCs in control conditions (black line, 
peaks at 4.7 and 7.9 pA) and in CNQX and SYM2081 (red). Dot-
ted lines are fi  ts of the distributions; binomial with single quantal 
size (7.9 pA, green dots; component 1) and compound fi  t with 
two quantal sizes (4.7 and 7.9 pA, blue triangles; component 2).264 Quantal ATP Release
might be somewhat ambiguous. The IC50 of PPADS for 
different subtypes of P2X receptors lies in the range 1–10 
μM (North and Surprenant, 2000), so 3 μM should effec-
tively inhibit P2X-mediated currents. On the other hand, 
one might not expect complete inhibition of purinergic 
current in the central nervous system because the P2X4 
subunit is most abundant, and receptors containing P2X4 
subunits are insensitive to suramin and PPADS (North 
and Surprenant, 2000).
Another possibility, that the small amplitude mEPSCs 
results from activation of kainate receptors (Cossart et al., 
2002) seems very unlikely in view of their persistence in 
50 μM CNQX, or 100 μM NBQX or 10 μM SYM2081. To 
exclude possible involvement of acetylcholin-mediated 
transmission, we treated cortical slices with hexameton-
ium. The latter is a classical open-channel blocker (Buisson 
and Bertrand, 1998), which effectively inhibits nico-
tinic cholinoreceptors when the cells are kept at hy-
perpolarized potentials (−80 mV in our case). The absence 
of any effect of hexamethonium (100 μM) does not 
fully exclude a contribution from nicotinic receptors, 
given that it is a relatively weak blocker of some central 
nicotinic receptors (e.g., α3β4 receptors; Winzer-Serhan 
and Leslie, 1997; Xiao et al., 1998). These caveats not-
withstanding, we proceed on the assumption that the 
small mEPSCs refl  ect activation of P2X receptors by ATP.
The ATP seems not to be released with glutamate (as 
was proposed for cultured CA3 neurones by Mori et al., 
2001) or with GABA (as was proposed for cultured lat-
eral hypothalamic neurones by Jo and Role [2002] and 
spinal neurones by Jo and Schlichter [1999]). In the fi  rst 
case, synchronous release of ATP and glutamate should 
lead to summation of mEPSCs, which would result in 
the appearance of the third, large-amplitude peak on 
the amplitude histogram. However, the mechanism of 
spontaneous ATP release clearly shares many features 
with the vesicular release of glutamate (sensitivity to 
α-latrotoxin, bafi  lomycin). In the second case, GABA- and 
ATP-mediated currents could be discriminated at −40 
mV (when ECl was −60 mV) because GABA currents 
were outward and P2X currents were inward. Obvi-
ously, if GABA was coreleased with ATP, the summation 
of inward and outward current events would lead to 
their mutual cancellation, hence reducing the overall 
frequency of mEPSCs. In fact, we did not observe any 
difference in mEPSC frequency between −80 and −40 
mV. On the other hand, our studies of eEPSCs provided 
no evidence for a pure “purinergic” nerve population. 
The experiments with paired-pulse inhibition, and 
the sensitivity to the presynaptic action of ACPT-1 and 
baclofen, are consistent with the interpretation that ATP 
is released from glutamate-containing fi  bers running 
vertically within the neocortex because thalamocortical 
inputs are reported to show paired-pulse inhibition (Gil 
et al., 1999; Reyes and Sakmann, 1999) and to be insen-
sitive to baclofen (Gil et al., 1997).
The analysis of evoked and miniature EPSCs indicates 
that the amplitude of the unitary event mediated by P2X 
receptors is about half the size of the unitary event medi-
ated by AMPA receptors (ratio in the range 0.4–0.8), 
whereas the probability of an ATP-mediated component 
to the postsynaptic current is lower (ratio in the range 
0.1–0.3). Our results also demonstrate that maximal 
number of quanta of ATP-mediated evoked synaptic cur-
rent depends on stimulus strength and, therefore, on 
the number of axons stimulated. The simplest interpre-
tation may therefore be that ATP is released from a dis-
tinct vesicle population at a subset of glutamatergic 
synapses. We cannot say with confi  dence whether this 
subset is defi  ned by its ability to release ATP or by the 
presence of postsynaptic P2X receptors (or both). The 
latter interpretation would be consistent with the elec-
tron microscopic fi  nding that P2X4 subunits are found at 
about one half of excitatory synapses (in hippocampus 
and cerebellum; Rubio and Soto, 2001). Alternatively, 
the ATP may be contained within vesicle with another 
“cotransmitter” such as a peptide. While considering all 
the possibilities outlined above we are acutely aware that 
the present paper does not answer all questions regard-
ing quantal release of ATP, and further understanding of 
the role on mechanisms of ATP release in central syn-
apses requires additional experimental efforts.
The overall contribution of ATP to the postsynaptic 
current is small because there is a lower probability of 
release and/or a lower number of ATP-containing ves-
icles as compared with those containing glutamate. In 
fact, the mean quantal content of the purinergic EPSC 
was three to four times lower than the quantal content 
of glutamate-mediated EPSC. Given that only some 
30–50% of synapses either release ATP or express P2X 
receptors, one could estimate the relative frequency of 
ATP-mediated events as 10–30%. This agrees with the 
relative frequency of purinergic mEPSCs (10–40% of 
control) as compared with glutamate mEPSCs. Thus, 
the purinergic excitatory synaptic input is minor in 
comparison to the glutamatergic input, even though 
the size of unitary ATP-mediated currents is actually 
about one half of the magnitude of glutamate-mediated 
currents. Nevertheless the ATP component can bring 
heterogeneity to the function of excitatory synapses, 
given that P2X receptors provide signifi  cant calcium 
entry and that, unlike the case for NMDA receptors, 
this entry does not require postsynaptic depolariza-
tion (Pankratov et al., 2002). The calcium entry itself 
may strengthen the synaptic connection over the lon-
ger term, particularly if the changes in intracellular 
calcium can bring either P2X or AMPA receptors to 
the membrane.
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